BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31486487)

  • 1. Preliminary results indicate increased expression of miR-184 in patients with renal carcinoma.
    Yang J; Lai CC; Xian ZM; Wang WQ; Xu BL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6878-6887. PubMed ID: 31486487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression.
    Zhang S; Hong Z; Li Q; Lei J; Huang H; Liu Q
    Biomed Pharmacother; 2016 May; 80():213-219. PubMed ID: 27133059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of microRNA-210 in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion.
    Liu TY; Zhang H; Du SM; Li J; Wen XH
    Genet Mol Res; 2016 Mar; 15(1):15017746. PubMed ID: 26985942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
    Wei RJ; Zhang CH; Yang WZ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑133b affects cell proliferation, invasion and chemosensitivity in renal cell carcinoma by inhibiting the ERK signaling pathway.
    Xu Y; Ma Y; Liu XL; Gao SL
    Mol Med Rep; 2020 Jul; 22(1):67-76. PubMed ID: 32377748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
    Wang X; Li H; Cui L; Feng J; Fan Q
    Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Dong ZC; Zhang D; Wang SB; Lin ZQ
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3018-3026. PubMed ID: 29863246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
    Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.
    Hirata H; Hinoda Y; Ueno K; Nakajima K; Ishii N; Dahiya R
    Carcinogenesis; 2012 Mar; 33(3):501-8. PubMed ID: 22180573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
    Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.